Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 3Urethral Neoplasms 3Carcinoma, Transitional Cell 3Ureteral Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 8Paclitaxel 7Therapeutics 6Flow Cytometry 5Radiotherapy 4Polymerase Chain Reaction 4Filgrastim 4Docetaxel 4Carboplatin 4Psychiatric Rehabilitation 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Methylprednisolone 3Interleukin-12 Subunit p35 3Immunoenzyme Techniques 3Gene Expression Profiling 3Cyclophosphamide 3Cisplatin 3Amplified Fragment Length Polymorphism Analysis 3sargramostim 2liposomal amphotericin B 2aflibercept 2Trastuzumab 2Taxes 2Prednisone 2Ondansetron 2Itraconazole 2Irinotecan 2Immunologic Techniques 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Ramucirumab × Genitourinary × Clear all
NCT03872947 2025-08-03

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Toray Industries, Inc

Phase 1 Active not recruiting
138 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡